Research News and Research

RSS

Transplanted pig cells may bring relief from insulin injections in type I diabetics

Living Cell Technologies, a New Zealand based biotechnology company that is investigating the use of living pig cells in the treatment of diabetes has now received $700,000 (US$500,000) grant from the Juvenile Diabetes Research Foundation International for further human trials.

28 Apr 2010

Canadian government says Canada's G8 maternal, child health plan will not include abortion

Canada on Monday at a meeting of G8 development ministers in Halifax, Canada, said its maternal and child health initiative, which is expected to be a "centerpiece issue" at the G8 summit in late June, will not include funding for abortion, the Associated Press/Washington Post (Gillies, 4/26).

28 Apr 2010

Myriad Genetics OnDose collection kit eliminates need for frozen sample handling

Myriad Genetics, Inc. today announced a significant improvement in the sample collection kit for OnDoseTM, its 5-Fluorouracil (5-FU) dose optimization product. Patient sample handling can now be conducted at room temperature, eliminating the need for frozen sample handling. Myriad said that it believes the simplified process should increase physician acceptance and utilization of OnDose.

28 Apr 2010

Pilot role-modeling program shows reduced and sustained body mass indexes in children

Weight Watchers has helped millions of American adults successfully lose weight and now results from a pilot, family-focused Weight Watchers approach designed to support parents shows potential for success in reducing excess weight in children, according to a study presented at the Experimental Biology Annual Meeting, Anaheim, Calif., April 27, 2010.

28 Apr 2010

Master's programs focus on new generation of health care management professionals

Health care management is growing in popularity among business schools, according to a report in the New York Times. "Health care is the target career for 10 percent of students working on a master of business administration degree at Harvard Business School," according to the Times. Many other universities are also highlighting programs that meld health care and management.

28 Apr 2010

DARA Therapeutics collaborates to advance clinical study of KRN5500 for CIPN in cancer patients

DARA BioSciences, Inc. announced today that on April 26, 2010, DARA Therapeutics, a subsidiary of DARA BioSciences, and the Division of Cancer Prevention, National Cancer Institute (NCI), National Institutes of Health (NIH), entered into a Clinical Trials Agreement to advance the clinical study of KRN5500 for the treatment of Chemotherapy Induced Peripheral Neuropathy (CIPN) in patients with cancer. Under the terms of the collaboration, NCI will fund the studies and DARA will supply KRN5500 and placebo.

28 Apr 2010

Companies providing home care receive large Medicare reimbursements

An analysis of Medicare payments to home health care companies by The Wall Street Journal indicates that some might be taking advantage of the system. According to the analysis, the industry's largest company, Amedisys Inc., "provided many of its patients just enough therapy visits to trigger the extra $2,200 payment.

28 Apr 2010

Study results from US Military Malaria Vaccine Program announced

Bioject Medical Technologies Inc., a leading developer of needle-free injection therapy systems, today announced that the US Military Malaria Vaccine Program presented results of its study using the Biojector2000 with a recombinant DNA vaccine at two recent conferences. A Cooperative Research and Development Agreement was signed with the Navy in April 2009 to work together on the study.

28 Apr 2010

Tel Aviv University researcher pioneers 3-D occupational therapy for children with disabilities

It was her love of ballet that led her to work with children who have motor disabilities. The retired dancer, now an occupational therapist, is pioneering a new "virtual" method to analyze movement patterns in children ― and more effectively treat those with debilitating motor disorders.

28 Apr 2010

NCCTG to conduct Phase II study of brostallicin in combination with cisplatin for mTNBC cancer

Cell Therapeutics, Inc. today announced that the North Central Cancer Treatment Group ("NCCTG") plans to conduct a Phase II study of brostallicin in combination with cisplatin in patients with metastatic triple-negative breast ("mTNBC") cancer, defined by tumors lacking expression of estrogen, progesterone receptors and without over-expression of HER2. Additionally, the majority of breast cancers that are associated with the susceptibility mutation (BRCA1) are of the triple-negative type.

28 Apr 2010

Commission on debt will focus on Medicare, Medicaid, Social Security

Lawmakers are prepping for a battle over the role of government in entitlements such as Medicare and Medicaid as a the Commission on Fiscal Responsbility and Reform prepares to begin work Tuesday, The Washington Post reports.

28 Apr 2010

Report looks at AIDS funding in developing countries

"A global pullback on commitments to fund and fight AIDS is resulting in restrictions on the number of people being enrolled into treatment programmes, more frequent drug shortages, and reduced national AIDS budgets," according to a report released Monday by the International Treatment Preparedness Coalition, BMJ News reports.

28 Apr 2010

Researchers receive $5.7M in funding to investigate new ways to treat uterine fibroids

As many as 75 percent of women have uterine fibroids (leiomyomas), and approximately one-third to one-half of those women become symptomatic at some point during their reproductive lives - experiencing irregular uterine bleeding, anemia, pelvic pain or recurrent pregnancy loss.

28 Apr 2010

Head- and neck-cancer patients who continue to smoke during radiation therapy have poorer overall survival

Smokers who don't quit before radiation therapy for throat, mouth and other head and neck cancers fair significantly worse than those who do, research from the UC Davis Cancer Center has found.

28 Apr 2010

Discovery Labs reports first-quarter results, updates on Surfaxin and key pipeline programs

Discovery Laboratories, Inc., a biotechnology company developing its novel synthetic surfactant and aerosol technologies for respiratory diseases, today provides an update on Surfaxin® and key pipeline and business initiatives and reports financial results for the first quarter ended March 31, 2010.

28 Apr 2010

Dietary MSC can help reset cell's biological clock to prevent development of breast cancer: Study

Usually when all else fails with a technical device, a "reset" button can be pressed, preventing a glitch from going any further. What if that could be done with threats to a person's health? Investigators from The Cancer Institute of New Jersey and the Environmental & Occupational Health Sciences Institute which is jointly administered by UMDNJ-Robert Wood Johnson Medical School and Rutgers, The State University of New Jersey, have discovered that a form of a dietary trace element known as selenium can help reset a cell's "biological clock" when it is disrupted by a chemical cancer-causing agent (carcinogen).

28 Apr 2010

Healthline Networks raises $14M through third round of financing led by IGC

Healthline Networks, the leading provider of intelligent health information services, today announced that it has raised $14 million in a third round of financing led by Investor Growth Capital (IGC), the wholly owned venture capital arm of Investor AB (Investor). The round also includes strategic financing from GE/NBC Universal's Peacock Equity Fund, a joint venture between GE Capital's Media, Communications & Entertainment business and NBC Universal and Reed Elsevier Ventures.

28 Apr 2010

News outlets continue malaria coverage

World Malaria Day was Sunday and news organizations continued to cover local events.

28 Apr 2010

Five-minute screening test could cut risk of developing bowel cancer: Research

A five-minute screening test could cut the risk of developing bowel cancer by a third and save thousands of lives from what is the UK's second biggest cancer killer, according to new research led by Imperial College London, published today in the Lancet.

28 Apr 2010

Laughter is truly the best medicine says new research

A new study has shown that laughter may be one of the simplest exercises that has similar effects on the body as pumping iron in the gym. Researchers have named “Laughercise” as significant elevators of mood, stress busters, immunity boosters and blood pressure and cholesterol reducers. It can also stimulate appetite for the malnourished.

28 Apr 2010

Research News and Research

Transplanted pig cells may bring relief from insulin injections in type I diabetics

Canadian government says Canada's G8 maternal, child health plan will not include abortion

Myriad Genetics OnDose collection kit eliminates need for frozen sample handling

Pilot role-modeling program shows reduced and sustained body mass indexes in children

Master's programs focus on new generation of health care management professionals

DARA Therapeutics collaborates to advance clinical study of KRN5500 for CIPN in cancer patients

Companies providing home care receive large Medicare reimbursements

Study results from US Military Malaria Vaccine Program announced

Tel Aviv University researcher pioneers 3-D occupational therapy for children with disabilities

NCCTG to conduct Phase II study of brostallicin in combination with cisplatin for mTNBC cancer

Commission on debt will focus on Medicare, Medicaid, Social Security

Report looks at AIDS funding in developing countries

Researchers receive $5.7M in funding to investigate new ways to treat uterine fibroids

Head- and neck-cancer patients who continue to smoke during radiation therapy have poorer overall survival

Discovery Labs reports first-quarter results, updates on Surfaxin and key pipeline programs

Dietary MSC can help reset cell's biological clock to prevent development of breast cancer: Study

Healthline Networks raises $14M through third round of financing led by IGC

News outlets continue malaria coverage

Five-minute screening test could cut risk of developing bowel cancer: Research

Laughter is truly the best medicine says new research

A guide to advancing biotherapeutic research eBook

Latest eBooks

A practical guide to lipid nanoparticle formulation and resizing

Editorial Focus eBook - Spatial and single-cell omics (1st edition)

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence